# Linaclotide for constipation-predominant IBS.

> PubMed lists PMID 24227771 in Drug and therapeutics bulletin as Journal Article, with publication-date metadata of 2013-11 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-24227771-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-11-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24227771-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-24227771-linaclotide-v1.json
- Content SHA-256: `08f0a61072e28f43a3de076212208540f5908bc4f2b5108566a58d61bab580d9`

## Claims and source pins

### Headline

Linaclotide for constipation-predominant IBS. ([`pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e`](#source-pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e))

### Summary

PubMed lists PMID 24227771 in Drug and therapeutics bulletin as Journal Article, with publication-date metadata of 2013-11 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e`](#source-pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e))

### Paragraph 1

PubMed lists PMID 24227771 in Drug and therapeutics bulletin as Journal Article, with publication-date metadata of 2013-11 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e`](#source-pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e`](#source-pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e))

## Sources

<a id="source-pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e"></a>
- **Linaclotide for constipation-predominant IBS. · retained source version 1:2017-11-16:current:616667c7d06ee2b038eb278b4f4e928b825290e2099b5523b5c4f465a3045b0f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24227771/) (`pubmed-observation-pmid-24227771-2017-11-16-616667c7d06e`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Linaclotide for constipation-predominant IBS." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-24227771-linaclotide-v1.json SHA-256: 08f0a61072e28f43a3de076212208540f5908bc4f2b5108566a58d61bab580d9.